1. 5-AZACYTIDINE IN COMBINATION WITH A NOVEL PAN-LYSYL OXIDASE INHIBITOR SYNERGISTICALLY RESTORES ERYTHROPOIESIS IN MYELODYSPLASTIC MALIGNANCIES. (May 2023) Authors: Xu, Q.; Streuer, A.; Jann, J.-C.; Altrock, E.; Schmitt, N.; Flach, J.; Sens-Albert, C.; Rapp, F.; Wolf, J.; Nowak, V.; Weimer, N.; Obländer, J.; Palme, I.; Kuzina, M.; Jawhar, A.; Darwich, A.; Weis, C.-A.; Marx, A.; Wuchter, P.; Costina, V. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Topic: AS08-Treatment/AS08e-New developments - Preclinical studies: A PRE-CLINICAL PATIENT-DERIVED XENOGRAFT MODEL OF MYELODYSPLASTIC SYNDROMES DEMONSTRATES EFFICACY AND SAFETY OF ELTROMBOPAG. (September 2021) Authors: Schmitt, N.; Jann, J.-C.; Altrock, E.; Flach, J.; Danner, J.; Uhlig, S.; Streuer, A.; Knaflic, A.; Riabov, V.; Xu, Q.; Mehralivand, A.; Palme, I.; Nowak, V.; Oblaender, J.; Weimer, N.; Haselmann, V.; Jawhar, A.; Darwich, A.; Weis, C.-A.; Marx, A. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗